Member Info for hants

Just looked on recent trades. At this moment it's an entire page of buys except for just one sell.

We haven't had any news though. Media coverage was great, but it's nothing investors didn't already know.

Avactas time will come. Sit tight!

I jonied the party last week, slightly late arrival but good to be into the blue already.

Redial - on what grounds?

Your previous posts with incorrect information have already destroyed any credibility you might have had. Perhaps it's time for you to make up another new user account?

And yes, it is busy here. Of course it is. The potential is massive so lots of people are either already invested or considering doing so.

Post reported.

Sirius B - I'm not sure that I agree. Most injections you get a benefit from, whether it's a treatment or a vaccine. Equally, most of the time when you're tested for something, it's because you think something is wrong so you WANT to have it done to find out.

If somebody feels fine and doesn't believe there's anything wrong with them, and they hate the idea of having a swab in their throat or in through their nose - will they get tested unless it's forced upon them? I'm certain a lot of people won't.

Wbernard. Put the question to Avacta on Twitter. Worst case scenario is they don't respond, but you might get the answer you're looking for.

Wbernard - I'm sure there's plenty of BB's you can discuss the science if that's what you want to do. I'm not sure what the point is you're trying to make on an investment BB.

Are you saying it can't be done? Because Avacta and Cytiva appear to think otherwise.

Are you saying it's difficult? If so then great, because that means less competition!

Continuing on from my previous posts, here's a couple of examples of articles. There's been posts, videos etc going around on Facebook too but I can't find them now.

Yes I know these are tabloids and yes, as said it probably depends on the person and who's doing it. The point is that these swab tests are unpleasant at best and I bet a LOT of people will go out of their way not to have it done, or to have it done as little as possible.

https://www.express.co.uk/news/uk/1262732/coronavirus-news-coronavirus-test-nasal-swab-covid19

https://www.mirror.co.uk/news/uk-news/woman-films-unsettling-coronavirus-nasal-21799007

Better a test which is 97% percent accurate that people will actually do, than a test which is 99% and everybody avoids it. (I've just made those % up, but you get my point).

I'm not going to attempt to enter into any scientific discussion because I don't have enough knowledge to do so.

Some thoughts, though - surely there will be a place for both types of tests, we won't see just one type being used?

If somebody asked me, "what's more accurate, a 10 minute quick test or lab test?" my answer would absolutely be lab test.

This is fine in locations such as hospitals where there's a lab and you can get a quick result, but we are talking about day to day life. People arriving for work, going to visit an elderly relative, boarding a plane, whatever.

There's also numerous news articles about the swabbing being painful. I have no idea if this is actually true (I guess it depends on how sensitive the subject is and how good to person doing the swabbing is), but that's going to put some people off getting tested voluntarily.

Finally, we have the issue of less developed countries where they aren't fortunate enough to have an abundance of labs and well eqiupped hospitals. What are they supposed to do?

I don't believe anybody is suggesting this will be as accurate (or should I say sensitive or specific to keep Wbernard happy?) as a lab test - and it's kind of missing the point anyway.

Do you mean some dissapeared? The host seems to struggle a bit when there's high traffic on a page. Refresh the page a couple of times and they should come back.

What's the dates on the articles? Do you have links? I've just found this quote but it's from 6th April.

It appears to be saying their existing operations won't be financially affected by Covid-19. I haven't researched this fully, perhaps somebody else can add further comment.
.............

The firm said its revenues were not expected to be materially affected in the current year as a direct result of the pandemic, and would continue to benefit from the expanded LG Chem partnership, the new collaboration established with ADC Therapeutics and the joint venture with Daewoong Pharmaceuticals.

"The company has made good progress in manufacturing drug material for the AVA6000 phase 1 clinical trial and in preparing the CTA filing," the board said.

"At this stage, the company does not expect to experience significant delays of more than a few weeks due to the Covid-19 pandemic, but it is reliant on clinical trials in the UK resuming by the end of the year."

WEEKEND NEWS AND IT WILL GAP UP ON OPEN TEN BAGS!! IMO, DYOR.

That's why.

I think you're right.

It's a Friday and I didn't even see anybody post... "wouldn't want to be out of this one over the weekend!!!"

£49.20?

I think the word is 'ambitious'.

Yes it did indeed, poor choice of words and in contrast to RNS.

For those who might be reading this who aren't aware, quote from recent RNS as follows:
"Avacta is already generating Affimer reagents that detect the COVID-19 virus and together with Cytiva will develop and manufacture a test capable of diagnosing the infection in minutes using a respiratory sample such as saliva."

My speculation:
It's entirely possible that he's aware of the drop in share price following the radio interview today, may have realised his wording error (which I assume is all it is) and will correct it next time. Wouldn't be surpised if there's more media converage over the weekend. We shall see.

I am down on this too. But I am not concerned.

I believe it will deliver.

Do you really think the CEO would be on the radio and Sky news if they couldn't do it?

-Company name clearly stated
-10 min Saliva test
-Roll out mass scale
-Direct to consumers
-Like pregnancy test
-To detect antigen you need reagent to detect viral partical. Takes time to development new one (months). But Avacta have the technology (Affimer) and can do it rapidly.
-Two or three weeks will know whether they sucessfully have new Affimer reagents.
-Mass scale rollout because test can be put onto a range of platforms such as lateral flow strips (Cytiva).
-Affimers could also be used in hospital high throughput capacity.

Correction - GDR isn't a 'lab test', but requires equpiment etc etc. You know what I mean!

I did the same yesterday Mapp. Sold GDR and bought more AVCT.

Before buying GDR I did a lot of research, but on reflection I just didn't have a good feeling about it. Also, I was somewhat betting against myself. When AVCT release their test, it's going to significantly detract from the market for lab testing. I appreciate there's more to GDR but I don't want to hold it long term, so I'm just talking about from a C19 perspective.